https://www.selleckchem.com/
5%) dMMR tumors (p less then 0.0001). Survival analyses revealed significant correlations between MMR-proficient (pMMR), PTEN expression, and a better outcome. The positive predictive value of PTEN-retained status for pMMR ranged from 94.6% in estrogen receptor (ER)+/HER2- tumors to 100% in HER2-amplified and ER-/HER2- cases. We propose a novel diagnostic algorithm where PTEN expression analysis can be employed to identify pMMR breast cancers.Fluorescent probes offer great potential to identify and treat surgical tumors by clinicians. To this end, several m
Like
Comment
Share
